Thursday, November 21, 2024 11/21/2024

Metalloenzyme structure, function, and as targets for neurodegeneration and bacterial pathogenesis

Award Number: R35GM131920
ORGANIZATION: NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

Group Awards By:

View Award Abstract

Heme is one of the most diverse and useful iron-containing cofactors in biology. One of the most diverse functions are in oxidative heme enzymes that are designed to store the oxidizing equivalents of H2O2 or O2 in order to carry out biologically useful oxidation reactions. These include detoxification of toxic peroxides and xenobiotics (ie drug metabolism) and the oxidation of small organic compounds in various biosynthetic pathways such as in steroid metabolism and antibiotic biosynthesis. Structural biology has played a critical role in understanding these enzymes and the Poulos lab has focused primarily, but not exclusively, on peroxidases, cytochromes P450, nitric oxide synthase (NOS), and the various auxiliary proteins required for electron transfer. Owing to the transient nature of redox partner complexes, it has been difficult to determine crystal structures which is why there are so few in the PDB. This gap in our knowledge is especially important in P450s where redox partner binding can play a critical role in controlling where the substrate is oxidized in addition to exerting an effector role critical for proton coupled electron transfer. Recent advances in the well known P450cam system has provided specific hypotheses on the structural changes induced by redox partner binding that are required for O2 activation and has resulted in a rethinking of traditional views on how P450s work. This has generated considerable discussion, some quite controversial, but also has stimulated research to test the validity of some of these new ideas. A critical question being addressed is the generality of redox partner effector control in P450 catalysis in addition to the biological basis for why such a level of control is required for some P450s but not others. NOS is a P450 and has provided deeper insights into O2 activation and substrate oxidation. NOS also has proven to be an important therapeutic target in neurodegenerative diseases and in certain pathogenic bacteria like methicillin resistant Staph aureus (MRSA). Together with the Silverman lab at Northwestern, structure-based methods are being applied to the development of highly selective NOS inhibitors. Overall, the various ongoing projects provide a synergistic mix of fundamental research in heme enzyme function with research having clearly defined biomedical relevance.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2025 ( Subtotal = $0 )
2025	2023	UNIVERSITY OF CALIFORNIA IRVINE	160 ALDRICH HALL	IRVINE	CA	92697	ORANGE	USA	Biomedical Research and Research Training	000	5	11/6/2024	NON-COMPETING CONTINUATION	$0
														Subtotal = $0

Issue Date FY: 2023 ( Subtotal = $595,980 )
2023	2023	UNIVERSITY OF CALIFORNIA IRVINE	160 ALDRICH HALL	IRVINE	CA	92697	ORANGE	USA	Biomedical Research and Research Training	001	5	9/13/2023	NON-COMPETING CONTINUATION	$0
2023	2023	UNIVERSITY OF CALIFORNIA, IRVINE	160 ALDRICH HALL	IRVINE	CA	92697	ORANGE	USA	Biomedical Research and Research Training	000	5	7/27/2023	NON-COMPETING CONTINUATION	$595,980
														Subtotal = $595,980

Issue Date FY: 2022 ( Subtotal = $595,980 )
2022	2022	UNIVERSITY OF CALIFORNIA, IRVINE	141 INNOVATION DR STE 250	IRVINE	CA	92617	ORANGE	USA	Biomedical Research and Research Training	000	4	5/23/2022	NON-COMPETING CONTINUATION	$595,980
														Subtotal = $595,980

Issue Date FY: 2021 ( Subtotal = $595,980 )
2021	2021	UNIVERSITY OF CALIFORNIA, IRVINE	141 INNOVATION DR STE 250	IRVINE	CA	92617	ORANGE	USA	Biomedical Research and Research Training	000	3	5/18/2021	NON-COMPETING CONTINUATION	$595,980
														Subtotal = $595,980

Issue Date FY: 2020 ( Subtotal = $595,980 )
2020	2020	UNIVERSITY OF CALIFORNIA, IRVINE	141 INNOVATION DR STE 250	IRVINE	CA	92617	ORANGE	USA	Biomedical Research and Research Training	002	2	5/13/2020	NON-COMPETING CONTINUATION	$595,980
2020	2019	UNIVERSITY OF CALIFORNIA, IRVINE	141 INNOVATION DR STE 250	IRVINE	CA	92617	ORANGE	USA	Biomedical Research and Research Training	000	1	4/30/2020	NEW	$0
2020	2019	UNIVERSITY OF CALIFORNIA, IRVINE	141 INNOVATION DR STE 250	IRVINE	CA	92617	ORANGE	USA	Biomedical Research and Research Training	001	1	4/30/2020	SUPPLEMENT FOR EXPANSION	$0
														Subtotal = $595,980

Issue Date FY: 2019 ( Subtotal = $540,859 )
2019	2019	UNIVERSITY OF CALIFORNIA, IRVINE	141 INNOVATION DR STE 250	IRVINE	CA	92617	ORANGE	USA	Biomedical Research and Research Training	000	1	5/24/2019	NEW	$475,976
2019	2019	UNIVERSITY OF CALIFORNIA, IRVINE	141 INNOVATION DR STE 250	IRVINE	CA	92617	ORANGE	USA	Biomedical Research and Research Training	001	1	8/7/2019	SUPPLEMENT FOR EXPANSION	$64,883
														Subtotal = $540,859

Grand Total All Awards = $2,924,779

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Metalloenzyme structure, function, and as targets for neurodegeneration and bacterial pathogenesis

Award Number: R35GM131920

ORGANIZATION: NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer